ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+38.95%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$1.27B
AUM Growth
+$1.27B
(+61%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
23.05%
Top 10 Holdings %
Top 10 Hldgs %
62.52%
Holding
50
New
7
Increased
21
Reduced
6
Closed
10
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$59.4M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$53.1M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$44.6M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$42.2M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$36M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$55.7M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$26.5M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$17.1M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$12.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$10.1M |
Sector Composition
| 1 | Healthcare | 68.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $206M | 15.98% | 14,739,461 +4,251,385 | +41% | +$59.4M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $97.1M | 7.53% | 6,437,122 +506,166 | +9% | +$7.63M |
|
|
KITE
3
DELISTED
Kite Pharma, Inc.
KITE
| $89.4M | 6.93% | 496,983 -309,767 | -38% | -$55.7M |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $65.8M | 5.11% | 5,353,029 +1,177,653 | +28% | +$14.5M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $64.7M | 5.02% | 785,700 +645,000 | +458% | +$53.1M |
|
|
MDCO
6
DELISTED
Medicines Co
MDCO
| $63.7M | 4.94% | 1,720,393 +611,293 | +55% | +$22.6M |
|
7
Ascendis Pharma
ASND
$11.8B
| $59.3M | 4.6% | 1,636,124 +645,200 | +65% | +$23.4M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $55.7M | 4.32% | 597,972 +97,183 | +19% | +$9.04M |
|
9
Pacira BioSciences
PCRX
$1.2B
| $49.2M | 3.82% | 1,311,460 +845,642 | +182% | +$31.8M |
|
|
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $44.6M | 3.46% | +3,516,100 | New | +$44.6M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $43.4M | 3.37% | 3,710,601 +1,435,200 | +63% | +$16.8M |
|
|
AVXS
12
DELISTED
AveXis, Inc. Common Stock
AVXS
| $42.2M | 3.28% | +436,702 | New | +$42.2M |
|
|
DERM
13
DELISTED
Dermira, Inc.
DERM
| $41M | 3.18% | 1,520,000 +195,000 | +15% | +$5.27M |
|
|
ZGNX
14
DELISTED
Zogenix, Inc.
ZGNX
| $36M | 2.79% | +1,026,368 | New | +$36M |
|
|
GBT
15
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $34.9M | 2.71% | 1,124,300 +264,300 | +31% | +$8.21M |
|
16
Iovance Biotherapeutics
IOVA
$807M
| $32.6M | 2.53% | 4,201,343 +50,000 | +1% | +$387K |
|
17
Assembly Biosciences
ASMB
$190M
| $31.7M | 2.46% | 907,162 +300,000 | +49% | +$10.5M |
|
|
TLGT
18
DELISTED
Teligent, Inc
TLGT
| $30.7M | 2.38% | 4,578,230 +447,430 | +11% | +$3M |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $25.2M | 1.95% | 195,092 -205,311 | -51% | -$26.5M |
|
20
Indaptus Therapeutics
INDP
$7.19M
| $19.7M | 1.52% | +2,195,705 | New | +$19.7M |
|
21
Vanda Pharmaceuticals
VNDA
$279M
| $17.7M | 1.37% | 988,270 +86,124 | +10% | +$1.54M |
|
|
AVEO
22
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $17.5M | 1.36% | 4,806,249 -1,826,203 | -28% | -$6.67M |
|
|
MYOK
23
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $17.1M | 1.32% | +398,207 | New | +$17.1M |
|
24
Catalyst Pharmaceutical
CPRX
$2.52B
| $11.7M | 0.91% | 4,635,745 +831,000 | +22% | +$2.09M |
|
|
AGEN
25
Agenus
AGEN
$133M
| $10.8M | 0.84% | 2,459,554 -724,274 | -23% | -$3.19M |
|